Paid Clinical Trials in Cypress, TX
As of July 2026, 38 paid clinical trials are recruiting in Cypress, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Cypress offers studies at sites including Houston Methodist Cypress Hospital for conditions such as Psychosis Associated With Alzheimer's Disease, Agitation, Alzheimer Disease, Alzheimer's Disease Psychosis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Cypress
Trials by drug in Cypress
Filter results
Newly added in Cypress
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
34 clinical trials
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
ACP-204 in Adults With Alzheimer's Disease Psychosis
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Bispectral Monitoring on Mechanically Ventilated Patients
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Top Research Study Locations in Cypress
Researchers run research studies in Cypress, TX at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Houston Methodist Cypress Hospital | Anatomic Stage II Breast Cancer AJCC v8, AL Amyloidosis, Advanced Lung Non-Squamous Non-Small Cell Carcinoma | 10 |
| Horizon Clinical Research Group | Alzheimer's Disease Psychosis, Lewy Body Dementia Psychosis, Asthma | 8 |
| APD Clinical Research | Acute Migraine, Migraine | 2 |
| Horizon Clinical Research Center - Houston | Agitation, Alzheimer Disease, Alzheimer's Disease | 2 |
| Horizon Clinical Research and Gill Neuroscience | Acute Migraine, Migraine | 2 |
| Clinical Research Solutions LLC | Focal Epilepsy | 1 |
| Horizon Clinical Research Center | Epilepsy, Healthy Volunteer | 1 |
| Horizon Clinical Research Center - Houston | Early Alzheimer's Disease | 1 |
| Horizon Clinical Research: Gill Neuroscience | Psychosis Associated With Alzheimer's Disease | 1 |
| Horizon Clinical Research: Gill Neuroscience - Houston | Parkinson Disease | 1 |
| Houston Meth Cypress Hosp | Lumbar Spinal Stenosis | 1 |
| Local Institution - 1106 | Psychosis Associated With Alzheimer's Disease | 1 |
| Local Institution - 2605 | Agitation, Alzheimer Disease | 1 |
| Mem Hermann Cypress Hosp | Lumbar Spinal Stenosis | 1 |
| Memorial Hermann Cypress Hospital | Sedation | 1 |
| Novartis Investigative Site | Atopic Dermatitis | 1 |
| Pioneer Research Solutions, Inc. | Chronic Kidney Diseases, Type 2 Diabetes Mellitus | 1 |
| Studies in Dermatology LLC | Atopic Dermatitis | 1 |
| Studies in Dermatology, LLC | Plaque Psoriasis | 1 |
| Syri Research Center | Chronic Obstructive Pulmonary Disease | 1 |
| Teva Investigational | Asthma | 1 |
Active & Upcoming Studies in Cypress (2026)
Recruiting trials in Cypress grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (9 active studies)
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · Phase 3 · National Cancer Institute (NCI)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
Neurology & pain (7 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (2 active studies)
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function · Phase 3 · AstraZeneca
- Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS · Phase 3 · DalCor Pharmaceuticals
Diabetes & metabolic (1 active study)
Common conditions studied in Cypress
- Psychosis Associated With Alzheimer's Disease (3 active studies)
- Agitation (2 active studies)
- Alzheimer Disease (2 active studies)
- Alzheimer's Disease Psychosis (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Asthma (2 active studies)
Leading research sponsors in Cypress
- ACADIA Pharmaceuticals Inc.
- Alliance for Clinical Trials in Oncology
- Bristol-Myers Squibb
- NRG Oncology
- Kallyope Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Cypress?
There are approximately 38 recruiting clinical trials in Cypress, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Cypress pay participants?
Most recruiting trials in Cypress compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Cypress?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Cypress?
The most common conditions under active study in Cypress include Psychosis Associated With Alzheimer's Disease (3), Agitation (2), Alzheimer Disease (2), Alzheimer's Disease Psychosis (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Cypress?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Cypress on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Cypress?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Cypress?
Recruiting research sites in Cypress include Houston Methodist Cypress Hospital, Horizon Clinical Research Group, APD Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Cypress right now?
The largest active categories in Cypress are Cancer & tumors (9), Neurology & pain (7), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.